Pharmasset, Inc. HomepageSitemapContact Us
About Pharmasset Therapeutic Areas Our Product Candidates Investor Center Careers Contact Us
www.Pharmasset.com July 29, 2010 07:40 PM

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Investor FAQs

Contact Us

Shareholder Tools

Email Alerts


Search Investor Relations



Download Library

Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.

Title Date Type Size  
Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C   PDF 72.0 KB Add to Briefcase
Audit_Committee_Charter_-_adopted_24Mar09.pdf   PDF 25.9 KB Add to Briefcase
Certificate of Incorporation   PDF 333.1 KB Add to Briefcase
Code of Ethics   PDF 42.1 KB Add to Briefcase
Corporate Governance Guidelines   PDF 21.4 KB Add to Briefcase
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients Apr 20, 2009 PDF 43.5 KB Add to Briefcase
Code of Ethics   PDF 61.9 KB Add to Briefcase
Audit Committee Charter   PDF 26.2 KB Add to Briefcase
Compensation Committee Charter   PDF 721.5 KB Add to Briefcase
Nominating and Governance Committee Charter   PDF 18.5 KB Add to Briefcase
Showing 1-10 of 10 Page: 1  
Add to Briefcase = add file to Briefcase
Pharmasset, Inc. Pharmasset, Inc. © 2010 . All Rights Reserved | Home | Top Return to Top
Site Design by Lakeshore Concepts